REJUVERON LIFE SCIENCES
DEAD

Serial Number

88708766

Owner

Rejuveron Life Sciences AG

Attorney

Paolo A. Strino

Filing Date

Nov 27, 2019

Add to watchlist:

No watchlists yet
View on USPTO

REJUVERON LIFE SCIENCES Trademark

Serial Number: 88708766 • Registration: 6236584

REJUVERON LIFE SCIENCES is a trademark filed by Rejuveron Life Sciences AG on November 27, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 36 (Insurance & Financial), Class 40 (Treatment & Processing), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Rejuveron Life Sciences AG (3 trademarks)

Wagistrasse 18

Entity Type: 99

Trademark Details

Filing Date

November 27, 2019

Registration Date

January 5, 2021

Published for Opposition

October 20, 2020

Cancellation Date

July 3, 2024

Goods & Services

Education services, namely, providing classes, seminars, workshops, and online tutorials in the field of life sciences and pharmaceuticals; providing of training in the field of life science and pharmaceuticals; planning and conducting of teaching, seminars and workshops in the fields of health, pharmacy, biotechnology, food science, food technology, agriculture and veterinary medicine

Custom manufacture of pharmaceuticals by pharmaceutical compounders for others to order; custom manufacture of pharmaceuticals to order and according to the requirements of a customer; custom manufacture of dental prosthesis and dentures to order and according to the requirements of a customer; processing of raw materials for further manufacture of the production of food and beverages

Dietary supplements and dietetic preparations adapted for medical purposes; hygienic preparations and articles, namely, disinfectants for hygienic purposes and disinfectants for medical purposes; dental preparations and articles, being for preventing and/or disclosing plaque and medicated dentifrices; pharmaceuticals and natural remedies for treating heart diseases, cancer, chronic lung diseases, neuronal conditions, gastrointestinal conditions; pharmaceutical preparations for treating migraine headaches, chronical diseases, traumatic and non-traumatic body injuries

Financial and monetary services, namely, financial consultancy, financial analysis, monetary exchange, and structural financial support; banking; financial and real estate valuation services; charitable, business, political fundraising and financial sponsoring of entertaining, sporting, and cultural events; real estate brokerage, agency, and investments services; insurance underwriting in the field of life, health, accident, and fire; pawn brokerage

Business data and management analysis, research and information services; retail and wholesale store services featuring medical products and dietary supplements; Providing consumer information in the field of longevity; organization of trade fairs for commercial purposes and providing related information to consumers; business assistance, management and administrative services; advertising, marketing and promotional services; retail and wholesale store services, and online retail and wholesale store services, in the fields of medicines, medical technology apparatus and devices, veterinary preparations, apparatus and devices, chemicals, foodstuffs, sanitary articles, agricultural products, and animal food

Preparation and dispensing of medications; providing information relating to the preparation and dispensing of medications; providing human hygienic and beauty care services; animal healthcare services; human healthcare services; agriculture services, namely, planting, growing, fertilizing, pruning and picking of agricultural plants for others; aquaculture services, namely, the cultivation and breeding of plants or animals in a water environment; horticulture and forestry services in the nature of gardening and landscaping services for others; dentistry; pharmaceutical consultancy services; medical services; advisory services relating to health

Prosthetic limbs, namely, arms, feet, legs, and artificial hip implants; orthopaedic and mobility aids, namely orthopaedic walkers, walkers to aid in mobility; medical and veterinary surgical apparatus and instruments; physical therapy equipment in the nature of foam rollers, manually-operated resistance tubing, weighted balls; medical equipment for physical exercises, namely, heart monitors to be worn during exercise

Scientific and technological services, namely, scientific research, analysis, testing, and clinical studies in the field of pharmaceuticals, life sciences; testing, authentication and quality control in the field of pharmaceuticals, life sciences and financial consulting; medical and pharmacological research services; medical laboratory services; computer programming in the medical field; scientific investigations for medical purposes; design and development of medical diagnostic apparatus; provision of information and data relating to medical and veterinary research and development; research and development in the fields of pharmacy, biotechnology, food science, food technology, agriculture and veterinary medicine; information relating to medical and scientific research in the fields of pharmacy, biotechnology, food science, food technology, agriculture and veterinary medicine; providing temporary use of online non-downloadable computer software for accessing, managing, updating and displaying electronic databases, in particular, in the fields of health, pharmacy, biotechnology, food science, food technology, agriculture and veterinary medicine; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; consultancy in the field of pharmaceutical research; providing information about the results of clinical trials for pharmaceutical products; pharmaceutical product evaluation; biological research, clinical research, all being medical research in the field of radiology, chemotherapy, coronary artery bypass surgery, cell and cancer research; biomedical research services; testing of pharmaceuticals; clinical research in the field of radiology, chemotherapy, coronary artery bypass surgery, and stem cell therapy; medical research; inspection of pharmaceuticals; consultancy relating to biotechnology research; biology research consultancy; biochemistry research consultancy; chemical research and analysis services; preparation of technical reports in the biotechnology field; genetic engineering services

Filing History

NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED
Jul 3, 2024 NCS7
CANCELLED SECTION 7-TOTAL
Jul 3, 2024 C7..
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 1, 2024 APRE
REQUEST FOR SECT 7 TOTAL SURRENDER FILED
Feb 6, 2024 C7RF
TEAS SECTION 7 SURRENDER RECEIVED
Feb 6, 2024 ES7S
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 29, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 29, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Aug 29, 2022 ECDR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Aug 29, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 29, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 29, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 29, 2022 COAR
REGISTERED-PRINCIPAL REGISTER
Jan 5, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 20, 2020 NPUB
PUBLISHED FOR OPPOSITION
Oct 20, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 30, 2020 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Sep 15, 2020 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Sep 11, 2020 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 8, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 8, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 8, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 8, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 8, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 2, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 1, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 1, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 3, 2020 GNRN
NON-FINAL ACTION E-MAILED
Mar 3, 2020 GNRT
NON-FINAL ACTION WRITTEN
Mar 3, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 2, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 4, 2019 NWOS
NEW APPLICATION ENTERED
Nov 30, 2019 NWAP